The Zeng group reported that the intraperitoneal injection of human recombinant IL-37 and the intravenous injection of IL-37 and troponin co-induced dendritic cells can alleviate the adverse ventricular remodeling after MI and attenuated the degree of cardiac fibrosis in mice [77]. Here, IL37 is linked to myocardial infarction.